Related references
Note: Only part of the references are listed.Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia
Ankita Patel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
Isabelle Vanden Bempt et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia
Shelly R. Gunn et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
Edurne Arriola et al.
LABORATORY INVESTIGATION (2008)
Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy
M. Hofmann et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Characterization of breast cancer by array comparative genomic hybridization
J. Climent et al.
BIOCHEMISTRY AND CELL BIOLOGY (2007)
Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive for false-negative immunohistochemistry?
Ciara Barrett et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Application of array-based comparative genomic hybridization to clinical diagnostics
Bassem A. Bejjani et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer
Lissandra Dal Lago et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry
M Salido et al.
BREAST CANCER RESEARCH (2005)
High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization
TL Naylor et al.
BREAST CANCER RESEARCH (2005)
Automated array-based genomic profiling in chronic lymphocytic leukemia:: Development of a clinical tool and discovery of recurrent genomic alterations
C Schwaenen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Profiling breast cancer by array CGH
DG Albertson
BREAST CANCER RESEARCH AND TREATMENT (2003)
Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma
AD Watters et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Real-world performance of HER2 testing - National surgical adjuvant breast and bowel project experience
S Paik et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831
PC Roche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Aneusomy 17 in breast cancer: Its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status
SJ Wang et al.
MODERN PATHOLOGY (2002)
Preservation of RNA for functional genomic studies: A multidisciplinary tumor bank protocol
SR Florell et al.
MODERN PATHOLOGY (2001)